Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Analytical Chemistry

Trifunctional Reagent Identifies Ligand-Receptor Interactions

TRICEPS sports moieties that link ligands and receptors and provide a handle for affinity purification

by Celia Henry Arnaud
September 24, 2012 | A version of this story appeared in Volume 90, Issue 39

A new trifunctional reagent allows researchers to identify ligand-receptor interactions in living cells and tissues, reports a Swiss team led by Erick Carreira and Bernd Woll-scheid of ETH Zurich (Nat. Biotechnol., DOI: 10.1038/nbt.2354). The TRICEPS reagent contains an N-hydroxysuccinimide ester that reacts with primary amines on ligands, a protected hydrazine that reacts with aldehydes in carbohydrates of glycoprotein receptors, and a biotin group that serves as a handle for affinity purification. These reagents enable ligand-based tagging of cell surface glycoproteins under near-physiological conditions and mass spectrometric identification of specific receptors. The researchers demonstrated the applicability of this ligand-based receptor-capture technology using insulin, transferrin, apelin, epidermal growth factor, the antibody trastuzumab, and two antibody mimetics to capture their respective cell surface receptors and to identify approximate ligand-binding sites. In collaboration with Jason Mercer from ETH Zurich, the researchers used intact vaccinia viruses as ligands to identify a binding factor panel consisting of five cell surface proteins for these highly complex viruses.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.